Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Lab Group Urges FDA To Wait For Congress On LDT Issue

Apr 07 2016

Related Content

CMS And FDA Stand Together Behind FDA Oversight Of LDTs At House Hearing

Nov 18 2015

House Diagnostics Reg Reform Draft Proposes Pathways For Relaxed Scrutiny

Oct 29 2015

Congress Will Not Tinker With FDA LDT Guidance Before Final, Staffers Indicate

Sep 10 2015

Lab Stakeholders Still Oppose FDA’s Multivariate Assay Policy

Sep 03 2007

FDA Aims To Finalize Framework For Lab-Developed Tests In Near Term

Jun 21 2010

Shuren In The Lion’s Den: Device Center Chief Defends LDT Plan At Clinical Lab Meeting, Fields Wide Array Of Questions

Mar 14 2016

Senate Moves To Floor Phase For Innovation Bill; Postmarket Surveillance, LDTs Could Get Attention

Apr 07 2016

FDA Plan To Regulate LDTs Includes Long Phase-In, Unmet-Need Exceptions

Jul 31 2014

Additional Topics

Innovation Manufacturing Legislation Legal Issues Personalized Medicine Regulation Medical Device

More from Legislation

More from Policy & Regulation

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window